Nell-1 Is a Key Functional Modulator in Osteochondrogenesis and Beyond

Area of Science:

• Regenerative Medicine and Orthopedics
• Molecular and Cellular Biology
• Developmental Biology

Background:

• Neural EGFL-like 1 (Nell-1) is a potent osteogenic factor with potential comparable to bone morphogenic protein 2 (BMP-2).
• Understanding Nell-1's mechanisms and therapeutic applications is crucial for advancing bone regeneration strategies.

Purpose of the Study:

• To review recent advancements in Neural EGFL-like 1 (Nell-1) research over the past decade.
• To explore Nell-1's structural and functional relevance, receptor identification, and role in skeletal development.
• To highlight Nell-1's therapeutic potential in bone regeneration and its advantages over BMP-2.

Main Methods:

• Review of existing literature on Nell-1, focusing on research from the last 10 years.
• Analysis of data from transgenic and tissue-specific knockout mouse models for skeletal development studies.
• Evaluation of preclinical animal models for bone regeneration and assessment of signaling pathways.

Main Results:

• Identification of contactin-associated protein-like 4 (Cntnap4) as a specific receptor for Nell-1 in osteogenesis.
• Demonstration of Nell-1's essential role in craniofacial and appendicular skeletal development using knockout models.
• Preclinical evidence supports Nell-1's efficacy in bone regeneration, showing synergistic effects with BMP-2 and unique anti-adipogenic, anti-inflammatory, and pro-vascular properties.

Conclusions:

• Nell-1 is a promising therapeutic agent for bone tissue engineering, offering advantages over BMP-2 and paving the way for clinical trials.
• Nell-1's osteogenic activity involves the MAPK and Wnt/β-catenin pathways, regulated by Runx2.
• Emerging evidence suggests Nell-1's involvement in chondrogenesis and potential roles in oral-dental and neural tissues warrant further investigation.